A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.
A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.
Recruiting · NCT06561555 · Registry updated 2024-12-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease. | Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, carcinoma, epithelial neoplasm, extramammary Paget disease, neoplasm | Recruiting | Phase 2 | 2024-12-17 | NCT06561555 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 257 |